MacroGenics Inc (NASDAQ:MGNX)
| 11.26 Delayed Data As of Jan 17 |  -0.33 / -2.85%Today’s Change | 7.43 Today|||52-Week Range 32.32 | +3.49% Year-to-Date |
Latest MGNX News | Press Releases
No recent news for MacroGenics Inc.
Today’s Trading
| Previous close | 11.59 |
| Today’s open | 11.66 |
| Day’s range | 11.19 - 11.85 |
| Volume | 401,394 |
| Average volume (3 months) | 543,776 |
| Market cap | $551.8M |
Data as of 4:00pm ET, 01/17/2020
Growth & Valuation
| Earnings growth (last year) | -675.81% |
| Earnings growth (this year) | +17.65% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -61.89% |
| P/E ratio | NM |
| Price/Sales | 8.65 |
| Price/Book | 1.97 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CLVSClovis Oncology Inc | +0.38 | +3.96% |
| ASMBAssembly Biosciences... | -0.11 | -0.62% |
| IPHAInnate Pharma SA | +0.34 | +4.61% |
| CRNXCrinetics Pharmaceut... | -1.12 | -4.50% |
Data as of 4:00pm ET, 01/17/2020
Financials
| Next reporting date | February 27, 2020 |
| EPS forecast (this quarter) | -$0.90 |
| Annual revenue (last year) | $60.1M |
| Annual profit (last year) | -$171.5M |
| Net profit margin | -285.18% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Rockville, Maryland |
Forecasts
